A study has explored the use of polygenic risk scores to predict treatment response in psychiatry, particularly in relation to electroconvulsive therapy (ECT). The research appears to have investigated the challenges and potential benefits of this approach. The study's focus includes treatment-resistant bipolar depression, with ECT being compared to other treatment methods.